Collectively, these results suggest that NAT10 induces the secretion of DKK2 by tumor cells and that DKK2 serves as an immune suppressive factor that restricts the recruitment of CD8+ T cells and impairs their cytotoxic function in CRC. The gene discussed is CD8A; the disease is neoplasm.